FSMAX | LSMNX | FSMAX / LSMNX | |
Total Expense Ratio | 0.04 | 0.83 | 4% |
Annual Report Gross Expense Ratio | 0.04 | 0.93 | 4% |
Fund Existence | 14 years | 6 years | - |
Gain YTD | 10.860 | 5.117 | 212% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 41.4B | 249M | 16,627% |
Annual Yield % from dividends | 0.44 | 0.00 | - |
Returns for 1 year | 12.72 | 4.81 | 265% |
Returns for 3 years | 63.57 | 33.52 | 190% |
Returns for 5 years | 48.84 | 12.70 | 385% |
Returns for 10 years | 103.74 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PCCOX | 66.30 | 0.35 | +0.53% |
T. Rowe Price U.S. Equity Research I | |||
SEKCX | 19.61 | 0.07 | +0.36% |
DWS Emerging Markets Equity C | |||
SVUIX | 40.60 | 0.11 | +0.27% |
NAA SMid Cap Value Institutional | |||
GSSUX | 42.81 | 0.07 | +0.16% |
Goldman Sachs Small Cap Value R6 | |||
CHCYX | 13.83 | -0.05 | -0.36% |
AB Discovery Growth Advisor |